NCT06915025: Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
- State
- Under way
- Phase
- Phase 3
- People
- 500 planned
- Started
- 9 Jul 2025
- Primary completion
- 31 Oct 2032
- Arms
- Experimental Arm: IMNN-001 + SOC Chemotherapy + SOC Maintenance Therapy
- Results
- None posted
- 7 Apr 2025: Trial registered
- 9 Jul 2025: Trial started